Application of the CRISPR/Cas9 System to Study Regulation Pathways of the Cellular Immune Response to Influenza Virus.

Animals CRISPR-Cas Systems / genetics Cell Line Chickens Gene Editing / methods Humans Immunity, Cellular Influenza A virus / genetics Virus Internalization Virus Replication
CRISPR/Cas9 CRISPR/Cas9 genome screening RNA processing factors cell receptors cellular immune response influenza virus

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
21 02 2022
Historique:
received: 28 12 2021
revised: 04 02 2022
accepted: 16 02 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 15 3 2022
Statut: epublish

Résumé

Influenza A virus (IAV) causes a respiratory infection that affects millions of people of different age groups and can lead to acute respiratory distress syndrome. Currently, host genes, receptors, and other cellular components critical for IAV replication are actively studied. One of the most convenient and accessible genome-editing tools to facilitate these studies is the CRISPR/Cas9 system. This tool allows for regulating the expression of both viral and host cell genes to enhance or impair viral entry and replication. This review considers the effect of the genome editing system on specific target genes in cells (human and chicken) in terms of subsequent changes in the influenza virus life cycle and the efficiency of virus particle production.

Identifiants

DOI: 10.3390/v14020437 PMID: 35216030 PMC: PMC8879999
pubmed: 35216030
pii: v14020437
doi: 10.3390/v14020437
pmc: PMC8879999
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Commun. 2020 Mar 6;11(1):1223
pubmed: 32144253
Viruses. 2017 Dec 07;9(12):
pubmed: 29215570
Nat Rev Drug Discov. 2020 Dec;19(12):839-859
pubmed: 33077937
BMB Rep. 2019 Feb;52(2):133-138
pubmed: 30078389
J Interferon Cytokine Res. 2011 Jan;31(1):49-57
pubmed: 21190483
Cell. 2009 Feb 20;136(4):642-55
pubmed: 19239886
J Biotechnol. 2015 Oct 10;211:56-65
pubmed: 26189696
Chem Sci. 2021 May 18;12(29):9934-9945
pubmed: 34377390
Nucleic Acids Res. 2018 Jul 6;46(12):5950-5966
pubmed: 29860520
PLoS Pathog. 2021 May 10;17(5):e1009517
pubmed: 33970958
Sci Rep. 2019 Mar 7;9(1):3801
pubmed: 30846846
Cell. 2018 Sep 20;175(1):212-223.e17
pubmed: 30241607
EMBO J. 2014 Apr 16;33(8):823-41
pubmed: 24668228
Cell Death Dis. 2020 Jun 15;11(6):463
pubmed: 32541772
Sci Rep. 2020 Jul 22;10(1):12166
pubmed: 32699298
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8682-6
pubmed: 15173583
PLoS Pathog. 2013;9(10):e1003663
pubmed: 24098121
Nature. 2012 Mar 25;484(7395):519-23
pubmed: 22446628
Front Immunol. 2020 Apr 30;11:678
pubmed: 32425931
Immunity. 2005 Jul;23(1):19-28
pubmed: 16039576
Cell Rep. 2018 Apr 10;23(2):596-607
pubmed: 29642015
Biochemistry. 2018 May 29;57(21):3027-3031
pubmed: 29746102
Brief Funct Genomics. 2011 Jul;10(4):215-26
pubmed: 21791555
Int J Mol Sci. 2021 Jun 04;22(11):
pubmed: 34200006
Eur J Cell Biol. 2014 Oct;93(10-12):466-77
pubmed: 25022758
J Bacteriol. 2008 Feb;190(4):1401-12
pubmed: 18065539
Science. 2018 Apr 27;360(6387):439-444
pubmed: 29449508
Stem Cell Res. 2019 Oct;40:101520
pubmed: 31445394
Cell. 2020 May 14;181(4):865-876.e12
pubmed: 32353252
Nat Immunol. 2011 Jun 05;12(7):624-30
pubmed: 21642987
Biosensors (Basel). 2021 Mar 19;11(3):
pubmed: 33808752
Trends Biotechnol. 2021 Jul;39(7):678-691
pubmed: 33972106
Annu Rev Virol. 2014 Nov 1;1:261-283
pubmed: 25599080
Front Immunol. 2019 Sep 12;10:2161
pubmed: 31572376
Antiviral Res. 2019 Aug;168:187-196
pubmed: 31176694
PLoS Pathog. 2021 Dec 6;17(12):e1010141
pubmed: 34871331
Cell Host Microbe. 2017 Sep 13;22(3):377-386.e5
pubmed: 28910636
Nature. 2019 Mar;567(7746):109-112
pubmed: 30787439
Chem Biol Interact. 2019 Aug 1;308:206-215
pubmed: 31136735
Nat Biotechnol. 2020 Jul;38(7):824-844
pubmed: 32572269
PLoS Pathog. 2018 Jan 19;14(1):e1006851
pubmed: 29352288
Annu Rev Biophys. 2017 May 22;46:505-529
pubmed: 28375731
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8676-81
pubmed: 15173599
J Immunol. 2011 May 1;186(9):5397-405
pubmed: 21444763
Cell Rep. 2020 Nov 3;33(5):108342
pubmed: 33147462
Trends Pharmacol Sci. 2022 Feb;43(2):151-161
pubmed: 34952739
Nat Rev Mol Cell Biol. 2014 Sep;15(9):591-600
pubmed: 25145850
EMBO J. 2000 Dec 15;19(24):6891-9
pubmed: 11118224
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2241-6
pubmed: 26858407
PLoS Pathog. 2016 Jul 20;12(7):e1005754
pubmed: 27438481
Clin Immunol. 2020 Aug;217:108469
pubmed: 32479990
Nucleic Acids Res. 2021 Jan 25;49(2):1173-1198
pubmed: 33398349
Nature. 2019 Dec;576(7785):149-157
pubmed: 31634902
NPJ Syst Biol Appl. 2017 Dec 4;3:35
pubmed: 29214055
Front Immunol. 2018 May 31;9:1193
pubmed: 29904383
Nat Commun. 2018 Aug 10;9(1):3199
pubmed: 30097581
Science. 2014 Mar 14;343(6176):1247997
pubmed: 24505130
Curr Opin Immunol. 2016 Feb;38:109-20
pubmed: 26761402
Appl Microbiol Biotechnol. 2019 Aug;103(16):6543-6557
pubmed: 31236615
Bioconjug Chem. 2019 Mar 20;30(3):931-943
pubmed: 30721034
Sci Rep. 2020 May 6;10(1):7635
pubmed: 32376987
Nat Immunol. 2019 Feb;20(2):173-182
pubmed: 30559377
Cell Host Microbe. 2013 Nov 13;14(5):510-21
pubmed: 24237697
Nat Rev Genet. 2004 May;5(5):355-65
pubmed: 15143318
J Virol. 2021 Mar 3;:
pubmed: 33658351
J Virol. 2010 Oct;84(20):10671-80
pubmed: 20686046
Biol Direct. 2013 Jun 15;8:15
pubmed: 23768067
Nature. 2016 Apr 20;533(7603):420-4
pubmed: 27096365
J Cell Biochem. 2019 Oct;120(10):16379-16392
pubmed: 31219653
J Inherit Metab Dis. 2021 Jan;44(1):72-87
pubmed: 32391605
PLoS Pathog. 2012;8(5):e1002712
pubmed: 22615570
Mol Cell. 2019 Dec 5;76(5):826-837.e11
pubmed: 31607545
Cell. 2009 Dec 24;139(7):1243-54
pubmed: 20064371
Nat Commun. 2020 Jan 9;11(1):164
pubmed: 31919360
Nature. 2010 Nov 4;468(7320):67-71
pubmed: 21048762
Nat Microbiol. 2020 Dec;5(12):1490-1503
pubmed: 32839537
Adv Virus Res. 2016;94:1-51
pubmed: 26997589
Nat Commun. 2020 Mar 9;11(1):1281
pubmed: 32152313
Nat Biotechnol. 2016 Jun;34(6):634-6
pubmed: 27159373
Front Genome Ed. 2021 Oct 13;3:745559
pubmed: 34723245
mBio. 2019 Dec 3;10(6):
pubmed: 31796537
J Exp Med. 2018 Oct 1;215(10):2567-2585
pubmed: 30143481
Cell. 2018 Apr 19;173(3):665-676.e14
pubmed: 29551272
J Bacteriol. 1987 Dec;169(12):5429-33
pubmed: 3316184
Nat Immunol. 2006 Feb;7(2):131-7
pubmed: 16424890
Stem Cell Res. 2021 Apr;52:102187
pubmed: 33582546
Gene Ther. 2021 Aug;28(7-8):396-401
pubmed: 34031549
Science. 2018 Apr 27;360(6387):444-448
pubmed: 29700266
Biostatistics. 2019 Apr 1;20(2):273-286
pubmed: 29394327
Stem Cell Res. 2019 Oct;40:101561
pubmed: 31526944
Cell Rep. 2017 Aug 15;20(7):1503-1512
pubmed: 28813663
PLoS Pathog. 2012 Sep;8(9):e1002909
pubmed: 22969429
Genes (Basel). 2020 Apr 02;11(4):
pubmed: 32252379
Nat Chem Biol. 2019 Mar;15(3):259-268
pubmed: 30643282

Auteurs

Daria Prokhorova (D)

Laboratory of Genome Editing, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.

Natalya Zhukova Eschenko (N)

Laboratory of Genome Editing, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Anna Lemza (A)

Laboratory of Genome Editing, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Mariia Sergeeva (M)

Laboratory of Genome Editing, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Laboratory of Vector Vaccines, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.
ORCID: 0000-0003-0411-9896

Rinat Amirkhanov (R)

Laboratory of Genome Editing, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Grigory Stepanov (G)

Laboratory of Genome Editing, Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
ORCID: 0000-0003-3393-3192

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Épigenèse génétique › Extinction de l'expression des gènes › Systèmes CRISPR-Cas › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Cellules › Cellules cultivées › Lignée cellulaire › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Oiseaux › Poulets › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Génie génétique › Édition de gène › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité acquise › Immunité cellulaire › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN de polarité négative › Orthomyxoviridae › Influenzavirus A › Virus de la grippe A › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Pénétration virale › Application of the CRISPR/Cas9 System to Study...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Réplication virale › Application of the CRISPR/Cas9 System to Study...